The vaccine is the first to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV) for older adults ages 60 and older.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA approves first RSV vaccine to protect older adultsUp to 10,000 deaths and 160,000 hospitalizations a year are caused by RSV.
Baca lebih lajut »
FDA approves world’s first RSV vaccine, a shot for older adultsIn a late-stage clinical trial, the single-dose shot lowered the risk of symptomatic illness by 83% and of severe illness by 94%.
Baca lebih lajut »
FDA Approves World’s First RSV Vaccine for Adults 60 and OlderResearchers first began attempting to develop a vaccine for respiratory syncytial virus, which is of particular danger to older people and infants, around 60 years ago.
Baca lebih lajut »
FDA approves world's first RSV vaccine, a shot for adults ages 60 and upBREAKING: FDA approves the world's first respiratory syncytial virus, or RSV, vaccine made by pharmaceutical giant GSK.
Baca lebih lajut »